GELS
Gelteq Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · AU
$0.43
−3.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.49x
- Price / sales
- 24.66x
- Price / cash flow
- -1.25x
Enterprise value
- Enterprise value
- $8.4M
- EV / sales
- 42.87x
- EV / EBITDA
- -2.26x
- EV / EBIT
- -1.89x
- Market cap
- $4.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025